Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

Overview of attention for article published in BMC Cancer, August 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 66 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,320 followers.

Efficacy & safety of lipegfilgrastim vs pegfilgrastim RCT in pts with breast ca receiving doxorubicin/docetaxel chemo http://t.co/vPZKEIn6kL

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.